TC
Tejpal Chauhan
About Tejpal Chauhan
Tejpal Chauhan has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Emdok Pharmaceuticals Private Limited and Bioneiser Pharmaceutical Private Limited. Formerly with 2 companies, such as Medok Lifesciences Private Limited and Gat Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Emdok Pharmaceuticals Private Limited
U24297CH2021PTC043628
|
Director | 15 Apr 2021 | 2021 | Active |
Bioneiser Pharmaceutical Private Limited
U46497CH2025PTC046115
|
Director | 01 Mar 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Medok Lifesciences Private Limited
U24232CH2010PTC031974
|
Director | 10 Apr 2010 | 2010 | Active |
Gat Pharmaceuticals Private Limited
U74999CH2016PTC041251
|
Director | 13 Oct 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejpal Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejpal Chauhan
Tejpal Chauhan has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Emdok Pharmaceuticals Private Limited and Bioneiser Pharmaceutical Private Limited. Formerly with 2 companies, such as Medok Lifesciences Private Limited and Gat Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Tejpal Chauhan is associated with 2 companies as Director.
Tejpal Chauhan has expertise in General Business.
Tejpal Chauhan has 16 years in corporate governance.